Eugia Pharma Receives USFDA Approval for Phenylephrine HCl Injection USP, 10 mg/mL Single-Dose Vials

Eugia Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Phenylephrine HCl Injection USP, 10 mg/mL Single-Dose Vials.

Indications for this product include:

•  Increasing blood pressure in adults with clinically important hypotension resulting primarily from vasodilation, in such settings as septic shock or anesthesia.

Refer to package insert for full prescribing information.